Aradigm’s Confidence Boosted by Novo Nordisk
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 53 (Table of Contents)
Published: 4 Nov-2004
DOI: 10.3833/pdr.v2004.i53.759 ISSN: 1756-7874
Section: General
Abstract
Aradigm and Novo Nordisk entered into a worldwide agreement to develop pulmonary insulin delivery system for administering insulin by inhalation, which is expected to enter phase II clinical trials...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS